Business
Notice of Results
Notice of Results.
About this update from Avacta Group Plc
[{"type":"text","content":"\n\n \n \nNotice of Results\n \nInvestor Presentation via Investor Meet Company\n \nLONDON and PHILADELPHIA - May 15, 2025 - Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to the tumor, will announce its audited preliminary results for year ended December 31, 2024 (\"FY24\") on May 29, 2025.\n \nChristina Coughlin, Chief Executive Officer and Brian Hahn, Chief Financial Officer will also deliver a live presentation via Investor Meet Company at 11:00 BST on the day.\nThe presentation is open to all existing and potential shareholders.\nInvestors can sign up to Investor Meet Company for free and add to meet AVACTA GROUP PLC via:\nhttps://www.investormeetcompany.com/avacta-group-plc/register-investor. Investors who already follow Avacta on the Investor Meet Company platform will automatically be invited.\nQuestions can be submitted pre-event via the Investor Meet Company dashboard up until May 29 09:00 BST, or at any time during the live presentation.\nThe Company will also post the results presentation on its website at the following page: https://avacta.com/investors/investor-resources/.\n \n-Ends-\n \nFor further information from Avacta, please contact:\n \n\n\n\n\nAvacta Group plc\nMichael Vinegrad, Group Communications\nDirector\n\n\nhttps://avacta.com/\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPeel Hunt (Nomad and Joint Broker)\nJames Steel / Chris Golden\n \n \n\n\n \nwww.peelhunt.com\n \n\n\n\n\nPanmure Liberum (Joint Broker)\nEmma Earl / Will Goode / Mark Rogers\n \n\n\nwww.panmureliberum.com\n\n\n\n\nICR Healthcare\nMary-Jane Elliott / Jessica Hodgson / Stephanie Cuthbert\n\n\n \[email protected]\n \n\n\n\n\n \nInvestor Contact\nRenee Leck\nTHRUST Strategic Communications\n \n\n\n \n \[email protected]\n \n\n\n\n\nMedia Contact\nCarly Scaduto\nCarly Scaduto Consulting\n\n\n \[email protected] \n\n\n\n\n \n \nAbout Avacta - www.avacta.com\nAvacta Therapeutics is a clinical-stage life sciences company expanding the reach of highly potent cancer therapies with the pre|CISION® platform. pre|CISION® is a proprietary warhead delivery system based on ...